PubMed

Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.

Lewis EJ, Xu X.

Diabetes Care. 2008 Feb;31 Suppl 2:S202-7. Review.PMID: 18227486 [PubMed - indexed for MEDLINE]Related articlesFree article

Involvement of human heparanase in the pathogenesis of diabetic nephropathy.

Katz A, Van-Dijk DJ, Aingorn H, Erman A, Davies M, Darmon D, Hurvitz H, Vlodavsky I.

Isr Med Assoc J. 2002 Nov;4(11):996-1002.PMID: 12489489 [PubMed - indexed for MEDLINE]Related articlesFree article

Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.

Wijnhoven TJ, van den Hoven MJ, Ding H, van Kuppevelt TH, van der Vlag J, Berden JH, Prinz RA, Lewis EJ, Schwartz M, Xu X.

Diabetologia. 2008 Feb;51(2):372-82. Epub 2007 Dec 6.PMID: 18058084 [PubMed - indexed for MEDLINE]Related articles

Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.

Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N.

Biochem Med Metab Biol. 1991 Feb;45(1):119-31.PMID: 2015105 [PubMed - indexed for MEDLINE]Related articles

Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients.

Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin D Jr, Gattuso P, Schwartz MM, Lewis EJ, Prinz RA, Xu X.

Diabetes. 2005 Jul;54(7):2172-8.PMID: 15983219 [PubMed - indexed for MEDLINE]Related articlesFree article

Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.

van den Born J, van Kraats AA, Bakker MA, Assmann KJ, van den Heuvel LP, Veerkamp JH, Berden JH.

Diabetologia. 1995 Feb;38(2):161-72.PMID: 7713310 [PubMed - indexed for MEDLINE]Related articles

Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.

Tamsma JT, van den Born J, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH, et al.

Diabetologia. 1994 Mar;37(3):313-20.PMID: 8174847 [PubMed - indexed for MEDLINE]Related articles

Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.

Gambaro G, Venturini AP, Noonan DM, Fries W, Re G, Garbisa S, Milanesi C, Pesarini A, Borsatti A, Marchi E, et al.

Kidney Int. 1994 Sep;46(3):797-806.PMID: 7527876 [PubMed - indexed for MEDLINE]Related articles

Pathogenesis of diabetic vascular disease: evidence for the role of reduced heparan sulfate proteoglycan.

Jensen T.

Diabetes. 1997 Sep;46 Suppl 2:S98-100. Review.PMID: 9285508 [PubMed - indexed for MEDLINE]Related articles

Changes in heparan sulfate correlate with increased glomerular permeability.

Groggel GC, Stevenson J, Hovingh P, Linker A, Border WA.

Kidney Int. 1988 Feb;33(2):517-23.PMID: 2452273 [PubMed - indexed for MEDLINE]Related articles

Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.

Garin EH, Shirey AJ.

Child Nephrol Urol. 1988-1989;9(3):121-6.PMID: 2978121 [PubMed - indexed for MEDLINE]Related articles

Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.

van den Hoven MJ, Wijnhoven TJ, Li JP, Zcharia E, Dijkman HB, Wismans RG, Rops AL, Lensen JF, van den Heuvel LP, van Kuppevelt TH, Vlodavsky I, Berden JH, van der Vlag J.

Kidney Int. 2008 Feb;73(3):278-87. Epub 2007 Nov 28.PMID: 18046314 [PubMed - indexed for MEDLINE]Related articles

Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy.

Tamsma JT, van der Woude FJ, Lemkes HH.

Nephrol Dial Transplant. 1996 Jan;11(1):182-5.PMID: 8649631 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy.

Yokoyama H, Sato K, Okudaira M, Morita C, Takahashi C, Suzuki D, Sakai H, Iwamoto Y.

Kidney Int. 1999 Aug;56(2):650-8.PMID: 10432405 [PubMed - indexed for MEDLINE]Related articlesFree article

No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy.

van den Born J, Pisa B, Bakker MA, Celie JW, Straatman C, Thomas S, Viberti GC, Kjellen L, Berden JH.

J Biol Chem. 2006 Oct 6;281(40):29606-13. Epub 2006 Aug 1.PMID: 16885165 [PubMed - indexed for MEDLINE]Related articlesFree article

[ACE inhibitor effects on structure and function of the glomerular basement membrane]

Hasslacher C, Bostedt-Kiesel A, Kempe HP.

Klin Wochenschr. 1992;69 Suppl 29:39-44. Review. German. PMID: 1614191 [PubMed - indexed for MEDLINE]Related articles

Heparanase in glomerular diseases.

van den Hoven MJ, Rops AL, Vlodavsky I, Levidiotis V, Berden JH, van der Vlag J.

Kidney Int. 2007 Sep;72(5):543-8. Epub 2007 May 23. Review.PMID: 17519955 [PubMed - indexed for MEDLINE]Related articles

Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion.

Kanwar YS, Linker A, Farquhar MG.

J Cell Biol. 1980 Aug;86(2):688-93.PMID: 6447156 [PubMed - indexed for MEDLINE]Related articlesFree article

Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane.

Groffen AJ, Veerkamp JH, Monnens LA, van den Heuvel LP.

Nephrol Dial Transplant. 1999 Sep;14(9):2119-29. Review.PMID: 10489220 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.

Sulikowska B, Olejniczak H, Muszyńska M, Odrowaz-Sypniewska G, Gaddi A, Savini C, Cicero AF, Laghi L, Manitius J.

Am J Nephrol. 2006;26(6):621-8. Epub 2006 Dec 21.PMID: 17191008 [PubMed - indexed for MEDLINE]Related articles